Pharmaceuticals stories
The new group could help New Zealand researchers turn lab breakthroughs into medicines, materials and cleaner industrial processes faster.
Europe's enterprise AI debate will centre on data sovereignty and governance as banks, drugmakers and universities gather in London.
The move puts workforce planning at the centre of OpenSky's expansion as it seeks faster delivery and tighter AI skills alignment.
Startups could file patent applications in days after Fearn raised USD $5.5 million to offer fixed-fee AI prosecution services.
The Montreal logistics group is overhauling its data governance as it seeks better forecasting, automation and operational visibility across North America.
Enterprise buyers now have a new tool to curb unpredictable AI bills as Guickly secures USD $4.2 million and targets shadow usage.
A bespoke office server now cuts a 70-slide medical presentation editing job from two and a half days to 15 minutes, keeping pharma data secure.
Rising demand for board-level hires in the UK and US has prompted the search firm to expand specialist coverage after client demand jumped 120%.
Enterprise users could gain a clearer path to quantum applications as Zapata and QuEra work to bridge today's hardware gap before fault-tolerant systems arrive.
The Auckland start-up will use the funds to develop capsules for microgravity research and manufacturing as demand grows for orbital access.
Enterprise demand for AI projects is driving Acceldata to expand in Europe, as firms seek sovereignty controls without lengthy data migrations.
Britain's life sciences start-ups could get a lift as the British Business Bank injects GBP £135 million into two Advent funds.
The appointment strengthens its board as demand rises for digital forensics and cyber security services handling ever-growing volumes of evidence.
The combined practice moves into India's top 10, as listed companies spend more on audit, controls and governance across sectors.
Nearly a third of UK exporters reported weaker June sales as higher costs and post-Brexit paperwork continued to squeeze margins.
Customer demand is helping the Boston and London startup expand as enterprises race to secure AI systems against fresh attack risks.
Shoppers could face higher prices, fewer choices and longer waits as Australian companies pass on rising supply chain costs.
Enterprises can now buy AI work by output, as the new marketplace aims to cut project costs and speed delivery across functions.
The tie-up could let researchers run more complex quantum algorithms on existing hardware without waiting for fault-tolerant machines.
Enterprises in Ireland can now buy dedicated 5G networks directly from Logicalis after a regulatory change opened spectrum to non-telecoms firms.